Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DORNASE ALFA Cause Condition aggravated? 304 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 304 reports of Condition aggravated have been filed in association with DORNASE ALFA (Pulmozyme). This represents 5.6% of all adverse event reports for DORNASE ALFA.

304
Reports of Condition aggravated with DORNASE ALFA
5.6%
of all DORNASE ALFA reports
27
Deaths
250
Hospitalizations

How Dangerous Is Condition aggravated From DORNASE ALFA?

Of the 304 reports, 27 (8.9%) resulted in death, 250 (82.2%) required hospitalization, and 25 (8.2%) were considered life-threatening.

Is Condition aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DORNASE ALFA. However, 304 reports have been filed with the FAERS database.

What Other Side Effects Does DORNASE ALFA Cause?

No adverse event (889) Cystic fibrosis (565) Off label use (522) Hospitalisation (512) Pneumonia (377) Dyspnoea (246) Infective pulmonary exacerbation of cystic fibrosis (245) Product storage error (242) Death (225) Cough (195)

What Other Drugs Cause Condition aggravated?

TOFACITINIB (16,925) INFLIXIMAB (16,616) DUPILUMAB (16,459) ETANERCEPT (15,897) METHOTREXATE (14,938) ADALIMUMAB (13,527) PREDNISONE (10,751) INFLIXIMAB-DYYB (10,275) HYDROXYCHLOROQUINE (8,848) RITUXIMAB (8,627)

Which DORNASE ALFA Alternatives Have Lower Condition aggravated Risk?

DORNASE ALFA vs DORZOLAMIDE DORNASE ALFA vs DORZOLAMIDE\TIMOLOL DORNASE ALFA vs DOSTARLIMAB DORNASE ALFA vs DOSTARLIMAB-GXLY DORNASE ALFA vs DOTATATE GALLIUM GA-68

Related Pages

DORNASE ALFA Full Profile All Condition aggravated Reports All Drugs Causing Condition aggravated DORNASE ALFA Demographics